These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 7356509)

  • 1. Preclinical Models for Bladder Cancer Research.
    Zhu S; Zhu Z; Ma AH; Sonpavde GP; Cheng F; Pan CX
    Hematol Oncol Clin North Am; 2021 Jun; 35(3):613-632. PubMed ID: 33958154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising mitomycin C activity during intravesical instillation.
    Jauhiainen K; Kangas L; Nieminen AL; Käpylä H; Alfthan O
    Urol Res; 1983; 11(2):59-62. PubMed ID: 6408779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
    Merk FB; Pauli BU; Jacobs JB; Alroy J; Friedell GH; Weinstein RS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Arai M; Cohen SM; Jacobs JB; Friedell GH
    J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of experimental bladder cancer.
    Bryan GT
    Cancer Res; 1977 Aug; 37(8 Pt 2):2813-6. PubMed ID: 326392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
    Shapiro O; Jones K; Wang C; Landas S; Haas GP
    Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder.
    Hodges GM; Hicks RM; Spacey GD
    Cancer Res; 1977 Oct; 37(10):3720-30. PubMed ID: 332338
    [No Abstract]   [Full Text] [Related]  

  • 12. Some ultrastructural aspects of experimental and human carcinoma of the bladder.
    Koss LG
    Cancer Res; 1977 Aug; 37(8 Pt 2):2824-35. PubMed ID: 326393
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.